The U.S. and China are scheduled to meet later this week. But chances aren’t good we’ll see any progress – at all. In fact, Vice Premier Liu He already noted his offer to the U.S. will not include commitments on reforming Chinese industrial policy or subsidies, as reported by Bloomberg. The problem is those are…
DetailsMarkets are in trouble. At the moment, the Dow Jones is well under its 50-day moving average, and could fall further unless there’s substantial news to push it higher. Adding to the pressure, the House Oversight Committee is now expected to issue a subpoena to the White House regarding Ukraine documents. President Trump is expected…
DetailsStock losses are accelerating. At the moment, the Dow Jones is now down 330 points. The NASDAQ shed 88, as the S&P 500 falls 35 points. All as U.S. manufacturing woes scare the Street. Just this morning, the ISM September survey on manufacturing registered at 47.8%, down from 49.1% from July. It’s also the 50.2%…
DetailsThis October, Canada may create a sizable opportunity for big cannabis stocks. A year after Canada legalized dried cannabis flower, oils, and sprays, the country is expected to legalize edibles, beverages, and topicals on October 17, 2019. Some of the top stocks to keep in mind, as we near that date include: Aurora Cannabis, which…
DetailsYou’re probably hearing a lot about the coming 5G boom. And there’s reason for that. Not only investors getting excited for the opportunity, analysts are, too. In fact, many believe 5G could usher in a $12 trillion opportunity. Cowen & Co. analysts have already called it a “revolution.” President Trump tweeted, “I want 5G, and…
DetailsHere are the top stories you may have missed. Two of the Top Biotech Stocks with Sizable Catalysts It’s tough to discount the bullish case for biotech and pharmaceutical stocks. For one, millions of retiring baby boomers not only exploring new ways to stave off signs of aging, they are looking to postpone health-related decline…
DetailsMistakes will be made, even by the pros. However, if you’re aware of potential issues, the better off you are. They Don’t Have a Trading Plan Experienced traders get into a trade with a plan. They know exact entry and exit points, the amount of capital to invest in the trade and the maximum loss they…
DetailsIt’s tough to discount the bullish case for biotech and pharmaceutical stocks. For one, millions of retiring baby boomers not only exploring new ways to stave off signs of aging, they are looking to postpone health-related decline and even death. In addition, we’re seeing countless mergers and acquisitions. We’re also seeing new, innovative treatments for…
DetailsThe markets aren’t too happy with the Federal Reserve this morning. All after the central bank cut rates by a quarter point to a range of 1.75% to 2%, disappointing many looking for a deeper cut. The bank also made it clear the cut was meant to serve as an insurance policy not against what’s…
DetailsUnbelievably, oil prices are already plunging. Just days after an attack knocked out 5.7 million barrels of crude production in Saudi Arabia, oil prices are pulling back on reports that production will return to normal faster than expected. In fact, crude is now down more than 6% on the news. All after the Saudis said…
DetailsOil prices skyrocketed on Monday. All after oil fields Saudi Arabia were attacked, taking 5.7 million barrels offline – or nearly 5% of global production. By midday Monday, oil was up $7 to nearly $62 a barrel. Unfortunately, this may not be the worst of it. “We assure the Saudi regime that our long hand…
DetailsREITs are one of the best opportunities on the market today. Especially with interest rates on the way down. Since 1960, REITs have beaten stocks by up to a full percentage point, according to a Netherlands’ report titled Historical Returns of the Market Portfolio. After examining global stocks between 1960 and 2017, researchers found that…
Details